We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Clarifies Manufacturing Requirements for FDFs
The European Medicines Agency issued draft guidance last month on the manufacture of finished dosage forms, clarifying the information drugmakers should include in the quality section of the common technical document in a premarket application.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor